FDA inspection
Enzon Pharmaceuticals, Inc: FDA inspection ending Mar 25, 2002
FDA inspection 208291 · No Action Indicated (NAI) · South Plainfield, NJ
Key facts
| Inspection ID | 208291 |
|---|---|
| Firm | Enzon Pharmaceuticals, Inc |
| FEI number | 2245253 |
| Address | 300 Corporate Ct |
| City | South Plainfield |
| State | NJ |
| ZIP | 07080-2415 |
| Fiscal year | 2002 |
| Inspection end date | Mar 25, 2002 |
| Classification | No Action Indicated (NAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data